Publication | Closed Access
Osimertinib benefit inEGFR-mutant NSCLC patients withT790M-mutation detected by circulating tumour DNA
162
Citations
22
References
2017
Year
OncologyTumour DnaSomatic VariantOncogenic AgentMedicineGeneticsPathologyCancer GenomicsCancer GeneticsMolecular Diagnostics
| Year | Citations | |
|---|---|---|
Page 1
Page 1